Orion Biotech Statements
OR
Data from Orion Biotech`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
31 Dec, 2022
Next reporting period:
31 Mar, 2023
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
—
Orion Biotech Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
—
0
0.204
0
0.204
-0.9 %
0
-0.204
0.9 %
0
1.492
0
—
0
1.288
40 %
0
—
0
1.288
40 %
0
0.052
25
—
—
100
—
0
—
—
0
—
0
0.205
0
0.205
0.5 %
0
-0.205
-0.5 %
0
1.126
0
—
0
0.92
-52.3 %
0
—
0
0.92
-52.3 %
0
0.037
25
—
—
100
—
0
—
—
0
—
0
0.205
0
0.205
-28.5 %
0
-0.205
28.5 %
0
2.134
0
—
0
1.929
-58.2 %
0
—
0
1.929
-58.2 %
0
0.077
25
—
—
100
—
0
—
—
0
—
0
0.286
0
0.286
39.6 %
0
-0.286
-39.6 %
0
4.904
0
—
0
4.618
615.6 %
0
—
0
4.618
615.6 %
0
0.185
25
—
—
100
—
0
—
—
0
—
0
0.205
0
0.205
-8.7 %
0
-0.205
8.7 %
0
-0.691
0
—
0
-0.896
-139.6 %
0
—
0
-0.896
-139.6 %
0
-0.036
24.72
—
—
100
—
0
—
—
0
—
0
0.224
0
0.224
46.1 %
0
-0.224
-46.1 %
0
2.489
0
—
0
2.264
210.6 %
0
—
0
2.264
210.6 %
0
0.091
25
—
—
100
—
0
—
—
0
—
0
—
0
0.154
240.7 %
0
-0.154
-240.7 %
0
—
0
-1.894
0
-2.048
-4442 %
0
—
0
-2.048
-4442 %
0
-0.082
25
—
—
100
—
0
—
—
0
—
0
0.045
0
0.045
—
0
-0.045
—
0
—
0
—
0
-0.045
—
0
—
0
-0.045
—
0
-0.002
25.75